A new Indigenous eye health study has recommended greater financial backing for non-clinical support providers, a critical factor that has been linked to improved patient appointment attendance.
Read more
National survey sheds new light on ophthalmology training
Ophthalmology trainees have indicated a high rate of satisfaction with their Vocational Training Program, according to the results of Australia’s first Medical Training Survey, released earlier this month. Read more
George & Matilda encourages staff to support fire affected communities
George & Matilda has created a new initiative to support communities affected by the 2020 bushfires by incentivising staff to get out and visit impacted regions. Read more
Australian CL manufacturer pens long-term deal with Chinese medical firm
Australia’s Capricornia Contact Lens is set to take its specialty products to the lucrative Chinese market after signing a 10-year distribution deal with a major pharmaceutical and medical equipment distributer. Read more
Questions over economic viability of MBS proposals
Proposed cuts to the rebate and fee for intravitreal injections will impact bulk billing services and access to treatment, Australia’s ophthalmic sector has warned. Read more
ADOA merger continues to progress
Recent changes to bylaws and constitutions are slowly bringing together Australia’s two dispensing organisations, following a 2019 commitment by the representative bodies to merge. Read more
QEI clinic unveils new cross-linking technology for corneal procedure
The Queensland Eye Institute (QEI) has become the first clinic in Australia to offer a new topography-guided corneal collagen cross-linking treatment to keratoconus patients. Read more
Warning to Australian eyecare professionals over coronavirus outbreak
Australian ophthalmologists have been warned that patients presenting with conjunctivitis could be infected with the deadly coronavirus, as the sector’s peak bodies urge eyecare professionals to be wary of people who have travelled from China. Read more
Novartis secures approval for AMD drug in Australia
Australia’s ophthalmic community has welcomed the approval of Novartis’ latest therapy for neovascular age-related macular degeneration (nAMD). Advocates hope the decision will lift treatment adherence rates across the country. Read more
Misconceptions and quirks of Australians unveiled in new eye health survey
Australia’s spending and hygiene habits have been laid bare in a survey that casts a new light on the country’s general attitudes and understanding of eyecare. Read more